The growing market of chemotherapy-induced peripheral neuropathy is driven by high prevalence, significant unmet need, and the increasing use of neurotoxic chemotherapies. Growing emphasis on survivorship and quality of life, along with the emergence of mechanism-based, disease-modifying...
Hence then, the article about chemotherapy induced peripheral neuropathy market to witness significant growth at a cagr of 14 2 during the forecast period 2026 2036 as novel therapies enter late stage development delveinsight was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Chemotherapy-Induced Peripheral Neuropathy Market to Witness Significant Growth at a CAGR of 14.2% During the Forecast Period (2026-2036) as Novel Therapies Enter Late-Stage Development .. DelveInsight )
Also on site :
- Die Phygital Contenders Astana 2026 gehen mit neuen Champions zu Ende - Qualifikationsrunden für die Games of the Future 2026 bestätigt
- Football upstages politics as Iranians rally behind their team at World Cup
- World Cup could deliver £7.6bn boost to UK economy – but ‘sickies’ may cost billions in lost productivity